Stock data
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN) reported net income of -US$8.77M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-04-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | — | — | -US$8.77M | -US$8.77M | — |
| 2025 | — | — | -US$4.50M | -US$4.51M | — |
| 2024 | — | — | -US$9.94M | -US$9.95M | — |
| 2023 | — | — | -US$14.87M | -US$14.88M | — |
| 2022 | — | — | -US$12.32M | -US$12.36M | — |
Quarterly results
Data as of 2026-07-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-07-31 | — | -US$3.03M | — |
| 2026-04-30 | — | -US$2.87M | — |
| 2026-01-31 | — | -US$2.20M | — |
| 2025-10-31 | — | -US$1.00M | — |
| 2025-07-31 | — | -US$2.70M | — |
| 2025-04-30 | — | -US$1.14M | — |
| 2025-01-31 | — | -US$1.04M | — |
| 2024-10-31 | — | -US$1.36M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.